| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 115,337 | 113,478 | 121,823 | 129,182 | | Cost of Revenue | 81,800 | 83,383 | 94,162 | 95,044 | | | Gross Profit | 33,537 | 30,095 | 27,661 | 34,138 | | | Operating Expenses | | Research Development | 5,534 | 5,870 | 4,638 | 5,148 | | Selling General and Administrative | 18,846 | 20,902 | 21,907 | 22,089 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,182 | 3,298 | 1,116 | 6,901 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (333) | (227) | 2,497 | (183) | | Earnings Before Interest And Taxes | 8,849 | 3,071 | 1,111 | 6,718 | | Interest Expense | 63 | 47 | 48 | 32 | | Income Before Tax | 8,786 | 3,024 | 1,063 | 6,686 | | Income Tax Expense | 3,937 | 1,592 | 720 | 2,524 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,849 | 1,432 | 343 | 4,162 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,849 | 1,432 | 343 | 4,162 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,849 | $1,432 | $343 | $4,162 |
|
0.51% Nasdaq 
Income Statement
